Missing/wrong data?
Log in to edit
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study
scientific article
Author/s
author: Lucas Moreno, Guy Makin, Alan V. Boddy, Darren Hargrave
Work details
Publication date
November 4, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.